Medicine and Dentistry
Mevalonic Acid
100%
Glycon
85%
Cancer Stem Cell
78%
Cell Population
35%
Therapeutic Procedure
28%
Enzyme
21%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
21%
Mammalian Target of Rapamycin
21%
Protein Prenylation
21%
Cells
21%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase Activator
14%
Xenograft
14%
Rapamycin
14%
5 Amino 4 Imidazolecarboxamide Riboside
14%
Tumor Spheroid Growth
14%
Tumor Progression
7%
Malignant Neoplasm
7%
Tumor Xenograft
7%
Cholesterol Synthesis
7%
Cell Marker
7%
Colorectal Cancer Cell Line
7%
Tumor Spheroid
7%
Chemotherapeutic Agent
7%
Drug
7%
Farnesyltransferase Inhibitor
7%
Simvastatin
7%
Statin
7%
Mammalian Target of Rapamycin Inhibitor
7%
Squalene Synthase Inhibitor
7%
Transferase Inhibitor
7%
Analysis
7%
Culture
7%
Defence Mechanisms
7%
Biochemistry, Genetics and Molecular Biology
Cancer Stem Cell
78%
Mevalonate Pathway
50%
AMP-activated Protein Kinase
35%
Lysozyme
21%
Tumor Spheroid
21%
Growth
21%
Protein Prenylation
21%
Experiment
14%
Cancer Cell
7%
Transferase
7%
CD44
7%
Simvastatin
7%
Synthase
7%
Cholesterol Synthesis
7%
CD133
7%
Stem Cell Marker
7%
Farnesyltransferase
7%
Staining
7%
Mouse
7%
Flow
7%
Defense Mechanism
7%
Statin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mevalonic Acid
100%
Enzyme
21%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
21%
Colorectal Cancer
21%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase Activator
14%
5 Amino 4 Imidazolecarboxamide Riboside
14%
Protein Farnesyltransferase Inhibitor
7%
Tumor Growth
7%
Simvastatin
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Drug
7%
Cell Marker
7%
Malignant Neoplasm
7%
Mammalian Target of Rapamycin Inhibitor
7%
Mouse
7%
Transferase Inhibitor
7%
Squalene Synthase Inhibitor
7%